Legal status by country
Is Lamivudine legal?
Written by Aaron CuhaReviewed Sep 2026
How Lamivudine is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Approved | Approved | Approved |
| Classification | FDA-approved, prescription only | Licensed, prescription only (MHRA) | TGA-registered, prescription only | Health Canada approved, prescription only |
| Note | Approved for HIV and hepatitis B. Use for ageing is off label. The label carries warnings about severe acute exacerbations of hepatitis B on discontinuation, which matters because someone taking it for ageing may not know their hepatitis B status. | Licensed for HIV and chronic hepatitis B. | None recorded | None recorded |
US FDA status: FDA approved for HIV-1 infection in combination therapy and, as a separate lower-dose product, for chronic hepatitis B. Not approved for ageing, inflammation or neurodegeneration.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.